Burmeister, B. H., & Smithers, B. M. (2005). Neoadjuvant chemoradiotherapy in resectable oesophageal cancer – Authors' reply. Lancet Oncology, 6(11), 825. https://doi.org/10.1016/S1470-2045(05)70402-2
Chicago Style (17th ed.) CitationBurmeister, Bryan H., and B Mark Smithers. "Neoadjuvant Chemoradiotherapy in Resectable Oesophageal Cancer – Authors' Reply." Lancet Oncology 6, no. 11 (2005): 825. https://doi.org/10.1016/S1470-2045(05)70402-2.
MLA (9th ed.) CitationBurmeister, Bryan H., and B Mark Smithers. "Neoadjuvant Chemoradiotherapy in Resectable Oesophageal Cancer – Authors' Reply." Lancet Oncology, vol. 6, no. 11, 2005, p. 825, https://doi.org/10.1016/S1470-2045(05)70402-2.
Warning: These citations may not always be 100% accurate.